[1] Mueller BU, Keller S, Seipel K, et al. Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity[J]. Leuk Lymphoma, 2015, 8(21): 1-8. DOI: 10.3109/10428194.2015.1079315. [2] Wang W, Yang L, Hu L, et al. Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity[J]. PLoS One, 2013, 8(5): e64660. DOI: 10.1371/journal.pone.0064660. [3] Hurley JH, Lee S, Prag G. Ubiquitinbinding domains[J]. Biochem J, 2006, 399(3): 361-372. [4] Okamoto Y, Ozaki T, Miyazaki K, et al. UbcH10 is the cancerrelated E2 ubiquitinconjugating enzyme[J]. Cancer Res, 2003, 63(14): 4167-4173. [5] Pickart CM, Eddins MJ. Ubiquitin: structures, functions, mechanisms[J]. Biochim Biophys Acta, 2004, 1695(1/3): 55-72. DOI: 10.1016/j.bbamcr.2004.09.019. [6] Weissman AM. Themes and variations on ubiquitylation[J]. Nat Rev Mol Cell Biol, 2001, 2(3): 169-178. DOI: 10.1038/35056563. [7] Welchman RL, Gordon C, Mayer RJ. Ubiquitin and ubiquitin-like proteins as multifunctional signals[J]. Nat Rev Mol Cell Biol, 2005, 6(8): 599-609. DOI: 10.1038/nrm1700. [8] Rajendra R, Malegaonkar D, Pungaliya P, et al. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53[J]. J Biol Chem, 2004, 279(35): 36440-36444. DOI: 10.1074/jbc.C400300200. [9] Guan GG, Wang WB, Lei BX, et al. UBE2D3 is a positive prognostic factor and is negatively correlated with hTERT expression in eso-phageal cancer[J]. Oncol Lett, 2015, 9(4): 1567-1574. DOI: 10.3892/ol.2015.2926. [10] Liu YB, Gao X, Deeb D, et al. Role of telomerase in anticancer activity of pristimerin in prostate cancer cells[J]. J Exp Ther Oncol, 2015, 11(1): 41-49. [11] Ren JW, Li ZJ, Tu C. MiR-135 posttranscriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells[J]. Int J Clin Exp Pathol, 2015, 8(6): 6356-6366. [12] Tokumoto M, Lee JY, Fujiwara Y, et al. Inorganic arsenic induces apoptosis through downregulation of Ube2d genes and p53 accumulation in rat proximal tubular cells[J]. J Toxicol Sci, 2013, 38(6): 815-820. [13] Li Y, Sun XX, Elferich J, et al. Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein[J]. J Biol Chem, 2014, 289(8): 5097-5108. DOI: 10.1074/jbc.M113.533109. [14] Polanowska J, Martin JS, GarciaMuse T, et al. A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites[J]. EMBO J, 2006, 25(10): 2178-2188. DOI: 10.1038/sj.emboj.7601102. [15] He X, Xiao X, Dong L, et al. MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1[J]. Tumour Biol, 2015, 36(3): 2065-2075. DOI: 10.1007/s13277-014-2814-z. [16] Mcginty RK, Henrici RC, Tan S. Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome[J]. Nature, 2014, 514(7524): 591-596. DOI: 10.1038/nature13890. |